Description
Treviamet Tablets (50 mg + 500 mg, 35’s) are a combination medication used to manage type 2 diabetes mellitus effectively. Each tablet contains Sitagliptin (50 mg) and Metformin (500 mg), which work together to improve blood sugar control. Sitagliptin is a DPP-4 inhibitor that enhances insulin secretion in response to meals, while Metformin reduces glucose production in the liver and improves insulin sensitivity. This dual-action approach is particularly beneficial for patients whose diabetes is not adequately controlled by diet and exercise alone. Treviamet is indicated for use as an adjunct to lifestyle modifications to achieve better glycemic control. It is essential to follow the prescribed dosage and consult a healthcare professional for personalized advice. Common side effects may include gastrointestinal discomfort, nausea, and headache, but these are generally mild and temporary.
